![]() |
인쇄하기
취소
|
Robert Wessman, President of Alvogen who raised the company through Generics, has come up with an unexpected strategy.
Alvogen, which succeed in acquiring Kunwha Pharmaceutical and Dream Pharma, has chosen OTC as the first testing bench in the Korean market.
Moreover, Alvogen decided to execute this strategy through Kunwha Pharmaceutical that has no experience in OTC market.
On September 25,...